Brimonidine Tartrate and Timolol

Generic Name: Brimonidine Tartrate and Timolol

Brand Names: -

Drug Type: -

Chemical Formula: -

CAS Number: -

Unique Ingredient Identifier: -

Indication: 用于降低开角型青光眼及高眼压症患者的眼内压。

Associated Conditions: -

Associated Therapies: -

Clinical Trials

The Relationship Between Intraocular Pressure and Macular Edema in Patients With Diabetic Macular Edema

Not Applicable

Conditions: Complications of Diabetes Mellitus

Interventions: Drug: Combigan

First Posted Date: 2016-03-24

Last Posted Date: 2017-03-28

Lead Sponsor: Meir Medical Center

Target Recruit Count: 25

Registration Number: NCT02718547

Locations: 🇮🇱
Meir Medical center, Kfar Saba, Israel

Prophylaxis for Anti-VEGF-induced IOP Elevation

Not Applicable

Withdrawn

Conditions: Ocular Hypertension

Interventions: Other: Refresh tears
Drug: Combigan

First Posted Date: 2015-12-07

Last Posted Date: 2023-05-22

Lead Sponsor: McMaster University

Registration Number: NCT02623023

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy